JP2012065652A5 - - Google Patents

Download PDF

Info

Publication number
JP2012065652A5
JP2012065652A5 JP2011214253A JP2011214253A JP2012065652A5 JP 2012065652 A5 JP2012065652 A5 JP 2012065652A5 JP 2011214253 A JP2011214253 A JP 2011214253A JP 2011214253 A JP2011214253 A JP 2011214253A JP 2012065652 A5 JP2012065652 A5 JP 2012065652A5
Authority
JP
Japan
Prior art keywords
cells
sendai virus
vector
cell
virus
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2011214253A
Other languages
English (en)
Japanese (ja)
Other versions
JP2012065652A (ja
Filing date
Publication date
Application filed filed Critical
Priority to JP2011214253A priority Critical patent/JP2012065652A/ja
Priority claimed from JP2011214253A external-priority patent/JP2012065652A/ja
Publication of JP2012065652A publication Critical patent/JP2012065652A/ja
Publication of JP2012065652A5 publication Critical patent/JP2012065652A5/ja
Pending legal-status Critical Current

Links

JP2011214253A 2003-11-04 2011-09-29 遺伝子導入された樹状細胞の製造方法 Pending JP2012065652A (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2011214253A JP2012065652A (ja) 2003-11-04 2011-09-29 遺伝子導入された樹状細胞の製造方法

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
JP2003374808 2003-11-04
JP2003374808 2003-11-04
JP2004187028 2004-06-24
JP2004187028 2004-06-24
JP2011214253A JP2012065652A (ja) 2003-11-04 2011-09-29 遺伝子導入された樹状細胞の製造方法

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
JP2005515163A Division JPWO2005042737A1 (ja) 2003-11-04 2004-10-29 遺伝子導入された樹状細胞の製造方法

Publications (2)

Publication Number Publication Date
JP2012065652A JP2012065652A (ja) 2012-04-05
JP2012065652A5 true JP2012065652A5 (enExample) 2012-12-20

Family

ID=34554806

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2005515163A Withdrawn JPWO2005042737A1 (ja) 2003-11-04 2004-10-29 遺伝子導入された樹状細胞の製造方法
JP2011214253A Pending JP2012065652A (ja) 2003-11-04 2011-09-29 遺伝子導入された樹状細胞の製造方法

Family Applications Before (1)

Application Number Title Priority Date Filing Date
JP2005515163A Withdrawn JPWO2005042737A1 (ja) 2003-11-04 2004-10-29 遺伝子導入された樹状細胞の製造方法

Country Status (8)

Country Link
US (1) US20070269414A1 (enExample)
EP (1) EP1690937B1 (enExample)
JP (2) JPWO2005042737A1 (enExample)
KR (1) KR101279748B1 (enExample)
CN (1) CN1902312B (enExample)
AU (1) AU2004286144A1 (enExample)
CA (1) CA2544786A1 (enExample)
WO (1) WO2005042737A1 (enExample)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2236378C (en) 1995-11-01 2011-01-25 Dnavec Research Inc. Recombinant sendai virus
US20030166252A1 (en) * 1999-05-18 2003-09-04 Kaio Kitazato Paramyxovirus-derived RNP
KR100854917B1 (ko) * 2000-03-30 2008-08-27 가부시키가이샤 디나벡크 겐큐쇼 센다이바이러스 벡터를 사용한 ａｉｄｓ 바이러스 백신
JP2002142770A (ja) * 2000-11-08 2002-05-21 Dnavec Research Inc 循環系への遺伝子送達用パラミクソウイルスベクター
JPWO2004038029A1 (ja) * 2002-10-24 2006-02-23 株式会社ディナベック研究所 Ｔ細胞に遺伝子を導入する方法
ATE459707T1 (de) * 2003-06-30 2010-03-15 Dnavec Research Inc Negativ-strang rna-virus-vektoren, welche ein gen mit veränderten hypermutierbaren regionen tragen
KR101279748B1 (ko) * 2003-11-04 2013-07-04 가부시키가이샤 디나벡크 겐큐쇼 유전자 도입된 수상세포의 제조방법
JPWO2005067981A1 (ja) * 2004-01-13 2007-12-27 株式会社ディナベック研究所 免疫刺激性サイトカインをコードするマイナス鎖ｒｎａウイルスベクターを用いる腫瘍の遺伝子治療
WO2005097988A1 (ja) * 2004-03-23 2005-10-20 Dnavec Research Inc. 組織の維持および／または修復に関連する骨髄関連細胞
AU2005257107A1 (en) 2004-06-24 2006-01-05 Dnavec Research Inc. Anticancer agent containing dendritic cell having RNA virus transferred thereinto
US20110162093A1 (en) * 2005-06-14 2011-06-30 Yasuji Ueda Methods for producing antibodies
EP1983048A4 (en) * 2006-01-17 2009-04-22 Dnavec Corp NEW PROTEIN EXPRESSION SYSTEM
WO2008136438A1 (ja) * 2007-04-27 2008-11-13 Kyushu University, National University Corporation 遺伝子治療用ウイルスベクター
EP2154243B1 (en) 2007-05-17 2016-01-13 ID Pharma Co., Ltd. Method for production of dendritic cell
EP2173374A2 (en) * 2007-07-24 2010-04-14 Stichting Katholieke Universiteit, Radboud University Nijmegen Medical Centre Compositions and methods for generating an immune response in a subject
US20110002940A1 (en) * 2007-08-30 2011-01-06 Academisch Ziekenhuis Bij De Universiteit Van Amsterdam Pathways involved in arteriogenesis and uses thereof
EP2262889B1 (en) * 2008-03-03 2017-05-03 University Of Toledo Method for the production of dendritic precursor cell line
KR101527260B1 (ko) 2008-11-14 2015-06-08 디나벡크 가부시키가이샤 수상세포의 제조방법
US10676723B2 (en) 2015-05-11 2020-06-09 David Gordon Bermudes Chimeric protein toxins for expression by therapeutic bacteria
US11129906B1 (en) 2016-12-07 2021-09-28 David Gordon Bermudes Chimeric protein toxins for expression by therapeutic bacteria
WO2020237315A1 (en) * 2019-05-31 2020-12-03 Telethon Kids Institute Immunogenic compositions

Family Cites Families (49)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6147186A (ja) 1984-08-09 1986-03-07 Chemo Sero Therapeut Res Inst インフルエンザウイルスの精製方法
JPS6147185A (ja) 1984-08-09 1986-03-07 Chemo Sero Therapeut Res Inst 日本脳炎ウイルスの精製方法
JPS6147187A (ja) 1984-08-10 1986-03-07 Chemo Sero Therapeut Res Inst 狂犬病ウイルスの精製方法
JPH084508B2 (ja) 1987-09-16 1996-01-24 国立予防衛生研究所長 組み換えワクチニアウイルス
US5124148A (en) * 1988-04-27 1992-06-23 United Cancer Research Institute Method for treating viral diseases with attenuated virus
JPH01285498A (ja) 1988-05-11 1989-11-16 Mitsubishi Heavy Ind Ltd 宇宙用パネル展開装置
TW232710B (enExample) 1991-09-13 1994-10-21 American Cyanamid Co
JPH05192160A (ja) 1992-01-20 1993-08-03 Banyu Pharmaceut Co Ltd Ｃ型肝炎ウイルスゲノムＲＮＡ、ｃＤＮＡ及びポリペプチド
WO1994008000A1 (en) 1992-10-06 1994-04-14 Akzo Nobel N.V. Pseudorabies virus vaccine
US6077519A (en) * 1993-01-29 2000-06-20 University Of Pittsburgh Methods for isolation and use of T cell epitopes eluted from viable cells in vaccines for treating cancer patients
EP1314431B1 (en) * 1993-04-30 2008-07-16 Wellstat Biologics Corporation Purified compositions of Newcastle disease virus
US5744144A (en) 1993-07-30 1998-04-28 University Of Pittsburgh University Patent Committee Policy And Procedures Synthetic multiple tandem repeat mucin and mucin-like peptides, and uses thereof
US5798100A (en) 1994-07-06 1998-08-25 Immunomedics, Inc. Multi-stage cascade boosting vaccine
US6300090B1 (en) * 1994-07-29 2001-10-09 The Rockefeller University Methods of use of viral vectors to deliver antigen to dendritic cells
KR100552387B1 (ko) * 1995-10-31 2006-04-21 가부시끼가이샤 디나벡 겡뀨쇼 자율 복제 능력을 갖는 (-)쇄 rna 바이러스 벡터
CA2236378C (en) * 1995-11-01 2011-01-25 Dnavec Research Inc. Recombinant sendai virus
US6734014B1 (en) * 1996-02-08 2004-05-11 The United States Of America As Represented By The Department Of Health And Human Services Methods and compositions for transforming dendritic cells and activating T cells
AU1733697A (en) 1996-02-29 1997-09-16 Takara Shuzo Co., Ltd. Method of purifying and removing viruses
WO1998053048A1 (en) * 1997-05-21 1998-11-26 The Government Of The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services Methods and compositions for making dendritic cells from expanded populations of monocytes and for activating t cells
US20030166252A1 (en) * 1999-05-18 2003-09-04 Kaio Kitazato Paramyxovirus-derived RNP
US7226786B2 (en) * 1999-05-18 2007-06-05 Dnavec Research Inc. Envelope gene-deficient Paramyxovirus vector
WO2000070070A1 (en) * 1999-05-18 2000-11-23 Dnavec Research Inc. Paramyxoviridae virus vector defective in envelope gene
DK1179594T3 (da) 1999-05-18 2008-09-01 Dnavec Research Inc Ribonukleoproteinkompleks i paramyxovirus
US20030022376A1 (en) * 1999-05-18 2003-01-30 Kaio Kitazato Paramyxovirus-derived RNP
EP1067179A1 (en) 1999-07-09 2001-01-10 Pierre Fabre Medicament Method to select attenuated paramyxoviridae useful for vaccines and therapeutics
US20020123479A1 (en) * 1999-12-08 2002-09-05 Song Elizabeth S. Immunostimulation mediated by gene-modified dendritic cells
US6472208B1 (en) * 1999-12-13 2002-10-29 Héma-Québec Method of producing human IFN-α using sendai virus-infected hematopoietic stem cells
KR100854917B1 (ko) * 2000-03-30 2008-08-27 가부시키가이샤 디나벡크 겐큐쇼 센다이바이러스 벡터를 사용한 ａｉｄｓ 바이러스 백신
CA2322057A1 (en) * 2000-05-18 2001-11-18 Dnavec Research Inc. Paramyxovirus vectors used for transfer of foreign genes
AU2002305452A1 (en) * 2001-05-08 2002-11-18 Emory University Regulating immine responses using dendritic cells
EP1509595A4 (en) * 2001-07-05 2006-02-22 Phylogix Inc METHODS FOR ISOLATING DENDRITIC CELLS
JP2005505270A (ja) * 2001-09-06 2005-02-24 ノースウエスト バイオセラピューティクス，インコーポレイティド 単球性樹状細胞およびｔ細胞にｔｈ−１応答をプライミングするための組成物および方法
KR20040039366A (ko) * 2001-09-18 2004-05-10 가부시키가이샤 디나벡크 겐큐쇼 입자 형성능이 저하된 （－）가닥 ｒｎａ 바이러스 벡터의 검사방법 및 제조방법
CA2462259A1 (en) * 2001-09-28 2003-04-10 Dnavec Research Inc. Mammalian cell-infecting virus vector encoding epitope-bound .beta.2m and utilization thereof
US20050048030A1 (en) * 2001-09-28 2005-03-03 Raymond Pickles Paramyxoviruses as gene transfer vectors to lung cells
FR2838123B1 (fr) * 2002-04-04 2005-06-10 Sanofi Synthelabo Nouveaux derives d'indolozine-1,2,3 substituee, inhibiteurs selectifs du b-fgf
JPWO2003102183A1 (ja) * 2002-06-03 2005-09-29 株式会社ディナベック研究所 抗体をコードするパラミクソウイルスベクターおよびその利用
AU2002951082A0 (en) * 2002-08-30 2002-09-12 The Corporation Of The Trustees Of The Order Of The Sisters Of Mercy In Queensland Therapeutic cellular agents
JPWO2004038029A1 (ja) * 2002-10-24 2006-02-23 株式会社ディナベック研究所 Ｔ細胞に遺伝子を導入する方法
US7785583B2 (en) * 2002-12-10 2010-08-31 Argos Therapeutics, Inc. In situ maturation of dendritic cells
KR101279748B1 (ko) * 2003-11-04 2013-07-04 가부시키가이샤 디나벡크 겐큐쇼 유전자 도입된 수상세포의 제조방법
JPWO2005067981A1 (ja) * 2004-01-13 2007-12-27 株式会社ディナベック研究所 免疫刺激性サイトカインをコードするマイナス鎖ｒｎａウイルスベクターを用いる腫瘍の遺伝子治療
AU2005206410A1 (en) * 2004-01-22 2005-08-04 Dnavec Research Inc. Method of producing minus strand RNA virus vector with the use of hybrid promoter containing cytomegalovirus enhancer and avian beta-actin promoter
CA2560046A1 (en) * 2004-03-16 2005-09-22 Dnavec Research Inc. Methods for suppressing tumor proliferation
WO2005097988A1 (ja) * 2004-03-23 2005-10-20 Dnavec Research Inc. 組織の維持および／または修復に関連する骨髄関連細胞
AU2005257107A1 (en) * 2004-06-24 2006-01-05 Dnavec Research Inc. Anticancer agent containing dendritic cell having RNA virus transferred thereinto
CA2605957A1 (en) * 2005-04-20 2006-10-26 Dnavec Corporation Highly safe intranasally administrable gene vaccines for treating alzheimer's disease
US20090246170A1 (en) * 2006-05-31 2009-10-01 Dnavec Corporation Therapeutic Agent For Alzheimer's Disease
EP2154243B1 (en) * 2007-05-17 2016-01-13 ID Pharma Co., Ltd. Method for production of dendritic cell

Similar Documents

Publication Publication Date Title
JP2012065652A5 (enExample)
JP2012130346A5 (enExample)
JP2016537982A5 (enExample)
JP2011125348A5 (enExample)
JP2016528894A5 (enExample)
JP2016521993A5 (enExample)
WO2013049121A3 (en) Recombinant phage and methods
JP2016501515A5 (enExample)
JP2012050449A5 (enExample)
JP2014501518A5 (enExample)
JP2013531978A5 (enExample)
JP2016518142A5 (enExample)
JP2015165823A5 (enExample)
JP2016500260A5 (enExample)
JP2016539641A5 (enExample)
JP2013516982A5 (enExample)
JP2013530680A5 (enExample)
JP2013517776A5 (enExample)
JP2014511118A5 (enExample)
IL232662B (en) Process for producing virus-like particles comprising enterobacteriophage ms2 capsid proteins
JP2017536826A5 (enExample)
WO2013033308A3 (en) Methods for tissue culture and transformation of sugarcane
MX2021009554A (es) Produccion de virus en cultivos celulares.
JP2016185168A5 (enExample)
WO2015042125A3 (en) Methods and compositions for producing hepatocyte-like cells